Drug Reaction with Eosinophilia and Systemic Symptoms after Daclizamub Therapy
Neurol 91:e359-e363, Rauer,S.,et al, 2018
Metronidazole-Associated Encephalopathy
NEJM 374:1465, Baden, L.R., 2016
Clinical Features, Diagnosis, and Treatment of Disseminated Intravascular Coagulation in Adults
UptoDate, Leung, L.L.K., 2015
Secondary Stroke Prevention With Ximelagatran Versus Warfarin in Patients With Atrial Fibrillation: Pooled Analysis of SPORTIF III and V Clinical Trials
Stroke 38:874-880, Akins,P.T.,et al, 2007
A 46-Year-Old Woman With Severe Weakness Following Acute Respiratory Distress Syndrome
Neurol 68:1529-1535, Waclawik,A.J.,et al, 2007
Ximelagatran vs Warfarin for Stroke Prevention in Patients with Nonvalvular Atrial Fibrillation
JAMA 293:690-698,736, SPORTIF Executive Steering Committee for the SPORTIF V Investigators, 2005
Medical Causes of Seizures
Lancet 352:383-390, Delanty,N.,et al, 1998
Valproic Acid Hepatic Fatalities. III. U. S. Experience Since 1986
Neurol 46:465-469, Bryant,A.E.&Dreifuss,F., 1996
Acute Hepatic Encephalopathy: Diffusion-Weighted and Fluid-Attenuated Inversion Recovery Findings, and Correlation With Plasma Ammonia Level and Clinical Outcome
AJNR 31:1471-1479, McKinney,A.M.,et al, 2010
Levetiracetam as a Possible Cause of Fulminant Liver Failure
Neurol 71:685-686, Tan,T.C.H.,et al., 2008
Liver Injury Associated with the B-Interferons for MS
Neurol 62:628-631, Tremlett,H.L.,et al, 2004
Fulminant Liver Failure During Interferon Beta Treatment of Multiple Sclerosis
Neurol 56:1416, Yoshida,E.M.,et al, 2001
Tolcapone and Hepatotoxic Effects
Arch Neurol 57:263-267, Olanow,C.W.&Tasmar Advisory Panel, 2000
Multisystem Hypersensitivity Reaction to Lamotrigine
Neurol 53:1367, Sarris,B.M.&Wong,J.G., 1999
Multiple Sclerosis, Side Effects of Interferon Beta Therapy and Their Management
Neurol 53:1622-1627, Walther,E.U.&Hohlfeld,R., 1999
Lamotrigine-Associated Anticonvulsant Hypersentivitiy Syndrome
Neurol 51:1171-1175, Schlienger,R.G.,et al, 1998
Tasmar (tolcapone) Labeling Revisions of Package Insert
Roche Laboratories, , 1998
Seizures in Medically Complex Patients
Epilepsia 38:S55-S59, Boggs,J.G., 1997
Felbamate-Associated Fatal Acute Hepatic Necrosis
Neurol 46:1457-1459, O'Neil,M.G.,et al, 1996
Fulminant Hepatic Failure Induced by Lamotrigine
BMJ 311:292, Makin,A.J.,et al, 1995
Anticonvulsant Hypersensitivity Syndrome
Arch Int Med 155:2285-2290, Vittorio,C.C.&Muglia,J.J., 1995
Complications of Intracranial Pressure Monitoring in Fulminant Hepatic Failure
Lancet 341:157-158, Blei,A.T.,et al, 1993
Dantrolene Sodium and Hepatic Injury
Neurol 40:1427-1432, Chan,C.H., 1990
Valproic Acid Hepatic Fatalities, II. US Experience Since 1984
Neurol 39:201-207, Dreifuss,F.E.,et al, 1989
Sodium Valproate
Editorial, Lancet 2:1229-12311988., , 1988
Valproic Acid Hepatic Fatalities:A Retrospective Review
Neurol 37:379-385, Dreifuss,F.E.,et al, 1987
Hypoglycemia:Causes, Neurological Manifestations, & Outcome
Ann Neurol 17:421-430, Malouf,R.,et al, 1985
Hypoglycemia:Fact or Fiction
Mayo Clin Proc 60:844-850, Nelson,R.L., 1985
Acute Hepatic Failure Associated with the Use of Sodium Valproate
NEJM 300:962-966, Suchy,F.J.,et al, 1979